Get Involved

Let’s build precision antibacterials

PhageCocktails is an open research-and-education project with a serious destination. If any of this resonates — the flagship NEC program, a frontier idea, the science, or the company-to-be — get in touch.

Researchers & clinicians

Collaborate on the NEC flagship or any of the 20 frontier concepts; contribute isolates, models, or expertise.

Funders & foundations

Back early, high-leverage work on precision antibacterials — from a single flagship program to the broader thesis.

Operators & founders

Help build the personalization infrastructure and the responsible commercial roadmap.

Journalists & students

Use this site as a sourced primer; ask for the underlying references or an interview.

Contact

Email hello@phagecocktails.com with a sentence on who you are and what you’re interested in. For the science behind anything on this site, ask and we’ll share the underlying references.

Connected to Microbiome Medicine and Karen Pendergrass.

Scientific & educational content. As of 2026 no bacteriophage therapeutic is approved as a marketed drug in the United States or European Union. Phage therapy is available only through clinical trials, compassionate-use / expanded-access pathways, and national magistral frameworks. Nothing here is medical advice or an offer to sell a therapeutic.